| Billylynn L. Han, Lcsw, Pllc | |
|
1601 2nd Ave N Ste 650 Great Falls MT 59401-3287 | |
| (406) 868-9824 | |
| Not Available |
| Full Name | Billylynn L. Han, Lcsw, Pllc |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 1601 2nd Ave N Ste 650, Great Falls, Montana |
| Authorized Official Name and Position | Billylynn Han (THERAPIST) |
| Authorized Official Contact | 4068689824 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Billylynn L. Han, Lcsw, Pllc Po Box 296 Black Eagle MT 59414-0296 Ph: (406) 868-9824 | Billylynn L. Han, Lcsw, Pllc 1601 2nd Ave N Ste 650 Great Falls MT 59401-3287 Ph: (406) 868-9824 |
| NPI Number | 1164047460 |
|---|---|
| Provider Enumeration Date | 06/11/2020 |
| Last Update Date | 06/11/2020 |
| Certification Date | 06/11/2020 |
| Medicare PECOS PAC ID | 1557784691 |
|---|---|
| Medicare Enrollment ID | O20200708003188 |
News Archive
Most schools in the U.S. are implementing healthy practices to help meet federal school meal standards by offering whole grains, more fruits and vegetables, and reducing sodium content, according to data published today in the Centers for Disease Control and Prevention's (CDC) Morbidity and Mortality Weekly Report.
Sudden infant death syndrome (SIDS), also called crib death or cot death, is the sudden and unexplained death of an infant less than one-year-old. There is no exact known cause of SIDS, but a recent study shows that mothers who smoked cigarettes and drank alcohol during pregnancy may have babies with a 12-fold increased risk of SIDS.
Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended September 26, 2009.
Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the presentation of new data at the Cell Culture Engineering XII conference held in Alberta, Canada from April 25 - 30, 2010. Alnylam Biotherapeutics was formed by Alnylam to develop RNAi technologies for application in manufacturing processes for biotherapeutic products, including recombinant proteins and monoclonal antibodies.
Enavail, LLC, a particle engineering company founded on pioneering drug delivery research from the University of Texas at Austin, announced today the company's plans for the construction of a new state-of-the-art current Good Manufacturing Practices (cGMP) facility in the Abilene Life Sciences Accelerator (ALSA). The Enavail facility will be the first of its kind in the West Texas region.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164047460 | NPI | - | NPPES |
| 1497318802 | Other | MT | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
| Provider Name | Billylynn Leiuilani Pestell |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1497318802 PECOS PAC ID: 2466875505 Enrollment ID: I20200708003224 |
News Archive
Most schools in the U.S. are implementing healthy practices to help meet federal school meal standards by offering whole grains, more fruits and vegetables, and reducing sodium content, according to data published today in the Centers for Disease Control and Prevention's (CDC) Morbidity and Mortality Weekly Report.
Sudden infant death syndrome (SIDS), also called crib death or cot death, is the sudden and unexplained death of an infant less than one-year-old. There is no exact known cause of SIDS, but a recent study shows that mothers who smoked cigarettes and drank alcohol during pregnancy may have babies with a 12-fold increased risk of SIDS.
Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended September 26, 2009.
Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the presentation of new data at the Cell Culture Engineering XII conference held in Alberta, Canada from April 25 - 30, 2010. Alnylam Biotherapeutics was formed by Alnylam to develop RNAi technologies for application in manufacturing processes for biotherapeutic products, including recombinant proteins and monoclonal antibodies.
Enavail, LLC, a particle engineering company founded on pioneering drug delivery research from the University of Texas at Austin, announced today the company's plans for the construction of a new state-of-the-art current Good Manufacturing Practices (cGMP) facility in the Abilene Life Sciences Accelerator (ALSA). The Enavail facility will be the first of its kind in the West Texas region.
› Verified 3 days ago
News Archive
Most schools in the U.S. are implementing healthy practices to help meet federal school meal standards by offering whole grains, more fruits and vegetables, and reducing sodium content, according to data published today in the Centers for Disease Control and Prevention's (CDC) Morbidity and Mortality Weekly Report.
Sudden infant death syndrome (SIDS), also called crib death or cot death, is the sudden and unexplained death of an infant less than one-year-old. There is no exact known cause of SIDS, but a recent study shows that mothers who smoked cigarettes and drank alcohol during pregnancy may have babies with a 12-fold increased risk of SIDS.
Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended September 26, 2009.
Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the presentation of new data at the Cell Culture Engineering XII conference held in Alberta, Canada from April 25 - 30, 2010. Alnylam Biotherapeutics was formed by Alnylam to develop RNAi technologies for application in manufacturing processes for biotherapeutic products, including recombinant proteins and monoclonal antibodies.
Enavail, LLC, a particle engineering company founded on pioneering drug delivery research from the University of Texas at Austin, announced today the company's plans for the construction of a new state-of-the-art current Good Manufacturing Practices (cGMP) facility in the Abilene Life Sciences Accelerator (ALSA). The Enavail facility will be the first of its kind in the West Texas region.
› Verified 3 days ago
Cmp Power Of Healing Counseling And Treatment Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1601 2nd Ave N, Great Falls, MT 59401 Phone: 406-468-8425 | |
Whole Life Therapeutics Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1601 2nd Ave N Ste 634, Great Falls, MT 59401 Phone: 406-231-1915 | |
Re Family Services Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 11 5th St N Ste 201, Great Falls, MT 59401 Phone: 406-204-1487 Fax: 406-315-3845 | |
Gateway Community Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 26 4th St N, Great Falls, MT 59401 Phone: 406-727-2512 | |
Open Door Wellness Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2022 Central Ave, Great Falls, MT 59401 Phone: 406-781-9867 Fax: 406-205-2358 | |
Big Sky Managed Care Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 900 13th Ave S, Great Falls, MT 59405 Phone: 406-315-1989 Fax: 406-315-1988 | |
Terri Flebotte, Lcsw Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 600 Central Ave, Suite 324, Great Falls, MT 59401 Phone: 406-952-1444 Fax: 406-559-3241 |